Drug:
Reaction: ASTHMA
20260101 - 20261231
No. 1001 - 1100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1001 | 26778335 |
US |
67 | 2 |
Nasopharyngitis, Asthma, Tremor, Limb discomfort, Injection site rash, Pain in extremity, Mobility decreased, Dyspnoea, Skin burning sensation, Injection site pruritus, Injection site erythema, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1002 | 26778353 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, AMLODIPINE AND ATORVASTATIN, FLUTICASONE FUROATE, DIPHENHYDRAMINE HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE, DOXEPN HYDROCHLORIDE, FLECAINIDE ACETATE TABLET, FLECAINIDE ACETATE, FUROSEMIDE, IRBESARTAN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, MONTELUKAST SODIUM, MONTELUKAST, ROSUVASTATIN CALCIUM, RIVAROXABAN, LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 1003 | 26778354 |
US |
2 | |
Angioedema, Peripheral swelling, Pain in extremity, Eye pruritus, Pruritus, Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1004 | 26778733 |
US |
53 | 2 |
Pneumonia, Asthma, Spinal operation, |
||||
DUPILUMAB, |
||||
| 1005 | 26778737 |
US |
57 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 1006 | 26779032 |
US |
2 | |
Glaucoma, Asthma, Seasonal allergy, Headache, Fatigue, Product dose omission issue, |
||||
ABALOPARATIDE, ALBUTEROL SULFATE, ALBUTEROL, BACLOFEN, BUDESONIDE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, MONTELUKAST, TIMOLOL MALEATE, TIMOLOL MALEATE OPHTHALMIC, |
||||
| 1007 | 26779042 |
US |
2 | |
Nephrolithiasis, Gastroenteritis clostridial, Ovarian cyst, Diarrhoea, Haematuria, Gastrooesophageal reflux disease, Seasonal allergy, Pulmonary calcification, Nausea, Cough, Pulmonary mass, Vasomotor rhinitis, Hyperlipidaemia, Infection, Dyspnoea, Abdominal pain, Conjunctivitis allergic, Seasonal allergy, Asthma, Bacterial infection, Breast mass, Wrist fracture, Renal cyst, Parathyroid disorder, Flank pain, Arthralgia, Hiatus hernia, Hypersensitivity, |
||||
DENOSUMAB, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, LOSARTAN POTASSIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, IPRATROPIUM BROMIDE, LEVALBUTEROL HYDROCHLORIDE, LEVALBUTEROL TARTRATE, LEVOCETIRIZINE DIHYDROCHLORIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, RANOLAZINE, ROSUVASTATIN CALCIUM, ERGOCALCIFEROL, |
||||
| 1008 | 26779584 |
US |
2 | |
Pseudomonas infection, Asthma, Dysphonia, Chest pain, |
||||
DUPILUMAB, ALBUTEROL SULFATE, DOFETILIDE, LOSARTAN POTASSIUM, LOSARTAN, METHOTREXATE, METHOTREXATE SODIUM, POLYETHYLENE GLYCOL 3350, MONTELUKAST SODIUM, MONTELUKAST, PREDNISONE, |
||||
| 1009 | 26779922 |
US |
61 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 1010 | 26780020 |
US |
2 | |
Off label use, Asthma, Urticaria, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 1011 | 26780438 |
US |
2 | |
Asthma, Pneumonia, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 1012 | 26780684 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 1013 | 26780977 |
US |
54 | 2 |
Brain fog, Asthma, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 1014 | 26781068 |
GB |
70 | 1 |
Asthma, |
||||
METRONIDAZOLE, METRONIDAZOLE TOPICAL, |
||||
| 1015 | 26781509 |
67 | 2 | |
Seizure, Seizure, Abdominal distension, Asthma, Head discomfort, Neuralgia, Burning sensation, Hyperaesthesia, Photopsia, Hyperacusis, Rash, Alopecia, Insomnia, Vomiting, Pruritus, Intentional underdose, Urticaria, Insurance issue, |
||||
TENAPANOR HYDROCHLORIDE, TENAPANOR HYDROCHLORIDE, PREGABALIN, LEVOTHYROXINE SODIUM, |
||||
| 1016 | 26781577 |
US |
75 | 2 |
Corneal transplant, Skin odour abnormal, Hypoacusis, Fall, Arthralgia, Gait inability, Arthritis, Hypertension, Dizziness, Pain, Electric shock sensation, Asthma, Pain in extremity, Back pain, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, HYDROMORPHONE HYDROCHLORIDE, GABAPENTIN, DUPILUMAB, |
||||
| 1017 | 26770891 |
US |
71 | 2 |
Asthma, Respiratory tract congestion, |
||||
DUPILUMAB, |
||||
| 1018 | 26771158 |
US |
2 | |
Asthma, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, |
||||
| 1019 | 26771198 |
US |
1 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 1020 | 26771204 |
US |
62 | 2 |
Pneumonia, Asthma, |
||||
DUPILUMAB, |
||||
| 1021 | 26771238 |
US |
55 | 1 |
COVID-19, Asthma, |
||||
DUPILUMAB, |
||||
| 1022 | 26771302 |
US |
2 | |
Asthma, |
||||
OMALIZUMAB, |
||||
| 1023 | 26771309 |
US |
56 | 2 |
Asthma, |
||||
OMALIZUMAB, PREDNISONE, |
||||
| 1024 | 26771431 |
US |
14 | 1 |
Asthma, Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 1025 | 26771469 |
US |
25 | 1 |
Cough, Pharyngitis streptococcal, Neuralgia, Hypoaesthesia, Breath sounds abnormal, Inappropriate schedule of product administration, Back pain, Injection site pain, Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1026 | 26771500 |
US |
2 | |
Asthma, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 1027 | 26771519 |
CA |
66 | |
Accident at work, Asthma, Blood pressure increased, Bronchitis, Chest discomfort, Productive cough, Discomfort, Dyspnoea, Ear infection, Environmental exposure, Forced expiratory volume decreased, Hypertension, Influenza, Insomnia, Lower respiratory tract infection, Malaise, Middle insomnia, Orthopnoea, Oropharyngeal pain, Perfume sensitivity, Wheezing, Respiratory distress, Rhonchi, Rib fracture, Seasonal allergy, Secretion discharge, Throat clearing, Weight decreased, Oral pain, Nasopharyngitis, Drug hypersensitivity, Weight increased, Pruritus, Cough, Fatigue, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CICLESONIDE, DESOXIMETASONE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, CANAGLIFLOZIN, |
||||
| 1028 | 26771565 |
US |
2 | |
Product dose omission issue, Asthma, Phobia, Injury associated with device, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 1029 | 26771752 |
US |
19 | 2 |
Pneumonia, Dyspnoea, Productive cough, Injection site reaction, Asthma, Therapeutic response decreased, |
||||
DUPILUMAB, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, ALBUTEROL SULFATE, MONTELUKAST SODIUM, MONTELUKAST, SERTRALINE HYDROCHLORIDE, |
||||
| 1030 | 26771868 |
CA |
15 | |
Parosmia, Throat irritation, Weight fluctuation, Asthma, Cough, Dizziness, |
||||
OMALIZUMAB, MONTELUKAST, MONTELUKAST SODIUM, TERBUTALINE SULFATE, |
||||
| 1031 | 26772089 |
US |
59 | 1 |
Asthma, Device failure, Injection site reaction, Injection site haemorrhage, Device malfunction, Product dose omission issue, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 1032 | 26772299 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 1033 | 26772315 |
AR |
80 | 2 |
Pneumonia, Asthma, |
||||
DUPILUMAB, |
||||
| 1034 | 26772363 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 1035 | 26772377 |
US |
2 | |
Dyspnoea, Asthma, Eosinophilia, |
||||
DUPILUMAB, |
||||
| 1036 | 26772387 |
US |
73 | 1 |
Asthma, |
||||
DUPILUMAB, |
||||
| 1037 | 26772737 |
US |
11 | 2 |
Pain in extremity, Oropharyngeal pain, Cough, Asthma, Dyspnoea exertional, |
||||
DUPILUMAB, |
||||
| 1038 | 26772762 |
US |
56 | 2 |
Pneumonia, Oxygen saturation decreased, Injection site pain, Asthma, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 1039 | 26772772 |
US |
46 | 2 |
Asthma, Drug ineffective, |
||||
DUPILUMAB, ABATACEPT, |
||||
| 1040 | 26772773 |
US |
48 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 1041 | 26772793 |
US |
42 | 2 |
Asthma, Sleep disorder due to a general medical condition, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, BUDESONIDE AND FORMOTEROL FUMARATE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PROPRANOLOL HYDROCHLORIDE, RIZATRIPTAN, SPIRONOLACTONE, |
||||
| 1042 | 26772804 |
GB |
70 | 1 |
Asthma, |
||||
METRONIDAZOLE, METRONIDAZOLE TOPICAL, |
||||
| 1043 | 26772932 |
US |
2 | |
Asthma, Cardiac disorder, Product dose omission issue, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, |
||||
| 1044 | 26773131 |
US |
55 | 2 |
Asthma, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 1045 | 26773145 |
US |
30 | 2 |
COVID-19, Malaise, Asthma, |
||||
DUPILUMAB, |
||||
| 1046 | 26773147 |
CA |
54 | 2 |
Pneumonia, Dry mouth, Nasal congestion, Residual symptom, Upper-airway cough syndrome, Fatigue, Respiratory tract irritation, Reflux laryngitis, Dysphonia, Productive cough, Temporomandibular pain and dysfunction syndrome, Snoring, Eustachian tube dysfunction, Dyspnoea, Nasal mucosal disorder, Arthralgia, Asthma, |
||||
DUPILUMAB, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, |
||||
| 1047 | 26773358 |
US |
65 | |
Asthma, Pruritus, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 1048 | 26773559 |
US |
2 | |
Asthma, Product colour issue, Eye pain, Unevaluable event, Multiple allergies, |
||||
CYCLOSPORINE, CYCLOSPORINE, PREDNISONE, |
||||
| 1049 | 26773677 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 1050 | 26774136 |
US |
50 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 1051 | 26774284 |
CA |
2 | |
Lower respiratory tract infection, Sinusitis, Asthma, |
||||
ALBUTEROL SULFATE, TIOTROPIUM BROMIDE INHALATION SPRAY, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, |
||||
| 1052 | 26774361 |
CA |
1 | |
Pneumonia, Asthma, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, TIOTROPIUM BROMIDE INHALATION SPRAY, |
||||
| 1053 | 26774534 |
US |
64 | 2 |
Autoimmune disorder, Concomitant disease aggravated, Dyspnoea, Cough, Throat clearing, Bronchitis, Chills, Sinus disorder, Asthma, Rhinorrhoea, Fatigue, Inflammation, |
||||
INCLISIRAN, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, |
||||
| 1054 | 26774670 |
US |
74 | 1 |
Asthma, |
||||
DUPILUMAB, |
||||
| 1055 | 26774993 |
US |
43 | 2 |
Asthma, |
||||
DUPILUMAB, IRON, MONTELUKAST SODIUM, TIRZEPATIDE, SERTRALINE HYDROCHLORIDE, |
||||
| 1056 | 26774999 |
US |
57 | 2 |
Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1057 | 26775177 |
US |
65 | 2 |
Asthma, |
||||
DENOSUMAB, UBROGEPANT, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, ROSUVASTATIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PANTOPRAZOLE SODIUM, NALOXONE HYDROCHLORIDE NASAL, NALOXONE HYDROCHLORIDE, MIRABEGRON, METOPROLOL SUCCINATE, METHOTREXATE, METHOTREXATE SODIUM, METHOCARBAMOL, MELATONIN, MAGNESIUM, LUBIPROSTONE, LIDOCAINE 4%, LIDOCAINE, LIDOCAINE 5%, LIDOCAINE, 0.5%, LIDOCAINE HCL 3%, LIDOCAINE 0.5%, LEVALBUTEROL TARTRATE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, IPRATROPIUM BROMIDE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, LEVOCETIRIZINE DIHYDROCHLORIDE, FAMOTIDINE, ESTRADIOL, DOCUSATE SODIUM, DIPHENHYDRAMINE HYDROCHLORIDE, DIAZEPAM, BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ABATACEPT, |
||||
| 1058 | 26775458 |
US |
37 | 1 |
Candida infection, Asthma, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, MEPOLIZUMAB, MONTELUKAST SODIUM, MONTELUKAST, TOPIRAMATE, BECLOMETHASONE DIPROPIONATE, FLUOROMETHOLONE, ALBUTEROL SULFATE, |
||||
| 1059 | 26775466 |
US |
2 | |
Middle insomnia, Asthma, |
||||
DUPILUMAB, ALBUTEROL SULFATE, |
||||
| 1060 | 26765474 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 1061 | 26765648 |
US |
25 | 1 |
Nasal congestion, Sneezing, Asthma, Off label use, Drug ineffective, Therapeutic response unexpected, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 1062 | 26765794 |
US |
1 | |
Pneumonia, Cholecystitis acute, Cholelithiasis, Asthma, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 1063 | 26765890 |
CA |
77 | 2 |
Pneumonia, Hospitalisation, Asthma, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, MONTELUKAST SODIUM, MONTELUKAST SODIUM, IPRATROPIUM BROMIDE, |
||||
| 1064 | 26765930 |
CA |
2 | |
Lower respiratory tract infection, Asthma, |
||||
| 1065 | 26765975 |
US |
2 | |
Asthma, Weight increased, Dyspepsia, Nausea, Constipation, |
||||
TIRZEPATIDE, |
||||
| 1066 | 26766078 |
CA |
2 | |
Cerebrovascular accident, Asthma, Memory impairment, |
||||
PREDNISONE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, |
||||
| 1067 | 26766164 |
US |
13 | 2 |
Hypersensitivity, Asthma, Therapeutic response shortened, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 1068 | 26766304 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Dyspnoea, Oedema, Pneumonia, Vomiting, Wheezing, |
||||
AMLODIPINE, CIPROFLOXACIN HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, RISEDRONATE SODIUM, RITUXIMAB, ROSUVASTATIN CALCIUM, TRAMADOL HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, AMINOPHYLLINE, CLONAZEPAM, FLUTICASONE PROPIONATE, FOLIC ACID, OMALIZUMAB, PREDNISOLONE SODIUM PHOSPHATE, MOXIFLOXACIN HYDROCHLORIDE, |
||||
| 1069 | 26766448 |
US |
62 | 2 |
Asthma, |
||||
DUPILUMAB, ALBUTEROL SULFATE, THYROID, PORCINE, BUDESONIDE AND FORMOTEROL FUMARATE, CARVEDILOL, CROMOLYN SODIUM, EPINEPHRINE, CALCIUM CARBONATE, SIMETHICONE, SIMETHICONE, ESCITALOPRAM, LOSARTAN POTASSIUM, LOSARTAN, MAGNESIUM, METHOCARBAMOL, METHOCARBAMOL TABLETS, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, TERBUTALINE SULFATE, ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, VITAMIN C, ERGOCALCIFEROL, WARFARIN SODIUM, WARFARIN, ZAFIRLUKAST, |
||||
| 1070 | 26766451 |
US |
56 | 2 |
Lower respiratory tract infection, Nasopharyngitis, Cough, Wheezing, Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1071 | 26766453 |
US |
27 | 2 |
Asthma, Dyspnoea, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1072 | 26766773 |
US |
47 | 1 |
Loss of consciousness, Cough, Catathrenia, Muscle spasms, Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1073 | 26767171 |
US |
50 | 2 |
Blood iron decreased, Weight decreased, Fatigue, Asthma, Sinus disorder, Malaise, Ear infection, Injection site mass, Laryngitis, Injection site swelling, Injection site pain, |
||||
DUPILUMAB, TIRZEPATIDE, FERROUS SULFATE, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, PREDNISONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, ATORVASTATIN CALCIUM, MONTELUKAST SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LOSARTAN POTASSIUM, LOSARTAN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, LEVOCETIRIZINE DIHYDROCHLORIDE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, FAMOTIDINE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, PAROXETINE HYDROCHLORIDE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, DUPILUMAB, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, VITAMIN E, ONDANSETRON HYDROCHLORIDE, NEMOLIZUMAB-ILTO, CETIRIZINE HYDROCHLORIDE, ERGOCALCIFEROL, ACETAMINOPHEN, INSULIN LISPRO, UMECLIDINIUM, DIPHENHYDRAMINE HYDROCHLORIDE, BENZONATATE, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, AMOXICILLIN AND CLAVULANATE POTASSIUM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 1074 | 26767375 |
CA |
6 | |
COVID-19, Asthma, Weight fluctuation, Product availability issue, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CICLESONIDE, MONTELUKAST SODIUM, ALBUTEROL SULFATE, |
||||
| 1075 | 26767629 |
GB |
69 | 2 |
COVID-19, Asthma, Product dose omission issue, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 1076 | 26767749 |
CA |
42 | |
Asthma, Chest discomfort, Dust allergy, Dyspnoea, Expiratory reserve volume decreased, Fall, Fear, Forced expiratory volume decreased, Frustration tolerance decreased, Herpes zoster, Ligament sprain, Lower respiratory tract infection, Obstructive airways disorder, Oropharyngeal pain, Productive cough, Respiratory tract congestion, Sensitivity to weather change, Smoke sensitivity, Perfume sensitivity, Wheezing, Throat clearing, Insomnia, Weight increased, Headache, Therapy non-responder, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, MONTELUKAST, ALBUTEROL SULFATE, |
||||
| 1077 | 26767848 |
US |
79 | 2 |
Asthma, Eczema, |
||||
DUPILUMAB, ALBUTEROL SULFATE, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, DIPHENHYDRAMINE HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 1078 | 26767910 |
US |
6 | 1 |
Asthma, |
||||
DUPILUMAB, |
||||
| 1079 | 26768519 |
51 | 1 | |
Dyspnoea, Fractional exhaled nitric oxide increased, Asthma, Pruritus, Eosinophil count increased, Oxygen saturation decreased, Product use in unapproved indication, Product prescribing issue, |
||||
| 1080 | 26768732 |
US |
44 | 2 |
Vertigo, Migraine, Asthenia, Fatigue, Head titubation, Asthma, Product dose omission issue, Rash, Product dose omission in error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1081 | 26768736 |
US |
54 | 2 |
Asthma, Dyspnoea, Palpitations, Dermatitis, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, MEPOLIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, LEBRIKIZUMAB-LBKZ, |
||||
| 1082 | 26768773 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Oedema, Pneumonia, Vomiting, |
||||
AMLODIPINE BESYLATE, CIPROFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, RISEDRONATE SODIUM, RITUXIMAB, ROSUVASTATIN, MONTELUKAST SODIUM, MONTELUKAST, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CALCIUM, CLONAZEPAM, ERGOCALCIFEROL, OMALIZUMAB, PREDNISONE, TRAMADOL HYDROCHLORIDE, |
||||
| 1083 | 26769246 |
US |
||
Sjogren^s syndrome, Rheumatoid arthritis, Systemic lupus erythematosus, Haemolytic anaemia, Asthma, Respiratory disorder, |
||||
RAVULIZUMAB, |
||||
| 1084 | 26769426 |
US |
2 | |
Eosinophilic pneumonia, Tendonitis, Hepatic cyst, Pneumonia, Dry skin, Blood glucose increased, Asthma, Migraine, Arthralgia, Fall, Fracture, |
||||
ASFOTASE ALFA, PREDNISONE, |
||||
| 1085 | 26770224 |
73 | 2 | |
Blood sodium decreased, Cerebral disorder, Blood pressure increased, Asthma, Fear of injection, Swelling face, Contraindicated product administered, |
||||
REPOSITORY CORTICOTROPIN, BIMEKIZUMAB, |
||||
| 1086 | 26770258 |
US |
43 | 1 |
Illness, Secretion discharge, Asthma, |
||||
DUPILUMAB, |
||||
| 1087 | 26770697 |
US |
2 | |
Rhinovirus infection, Asthma, Chest discomfort, Headache, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 1088 | 26764221 |
US |
62 | 2 |
Bronchitis, Asthma, |
||||
DUPILUMAB, |
||||
| 1089 | 26764241 |
AU |
4 | 2 |
Asthma, Product dose omission issue, Product complaint, |
||||
FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, |
||||
| 1090 | 26764250 |
US |
2 | |
Asthma, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 1091 | 26764339 |
US |
12 | 1 |
Urticaria, Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1092 | 26764517 |
US |
2 | |
Asthma, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 1093 | 26764736 |
US |
63 | 2 |
Stress, Peripheral swelling, Sensitive skin, Condition aggravated, Pruritus, Asthma, |
||||
DUPILUMAB, |
||||
| 1094 | 26764740 |
US |
41 | 2 |
Asthma, Eosinophil count increased, Rash, Off label use, |
||||
DUPILUMAB, |
||||
| 1095 | 26765018 |
GB |
55 | 1 |
Fungal infection, Urticaria, Psoriasis, Pustular psoriasis, Psoriasis, Cough, Injection site rash, Asthma, Fatigue, Medication error, |
||||
GOLIMUMAB, |
||||
| 1096 | 26765047 |
US |
2 | |
Arthralgia, Nasal polyps, Asthma, Dyspnoea, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 1097 | 26765121 |
BR |
2 | |
Pneumonia, Asthma, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 1098 | 26765246 |
CA |
43 | 2 |
Asthma, Blepharospasm, Blood cholesterol increased, Decreased appetite, Chest pain, Contusion, Deep vein thrombosis postoperative, Depression, Diarrhoea, Dizziness, Dry mouth, Exposure during pregnancy, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Headache, Hepatic enzyme increased, Hypertension, Hypocholesterolaemia, Impaired healing, Infusion related reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lung disorder, Memory impairment, Muscle spasms, Night sweats, Osteoarthritis, Paraesthesia, Retinitis, Rheumatoid arthritis, Stomatitis, Urticaria, Visual impairment, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, CANDESARTAN, CANDESARTAN, CANDESARTAN, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PHENYLEPHRINE HYDROCHLORIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ERENUMAB-AOOE, SULFASALAZINE, BUPRENORPHINE HYDROCHLORIDE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, ERGOCALCIFEROL, FLUTICASONE PROPIONATE, LEFLUNOMIDE, LEFLUNOMIDE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MINOCYCLINE HYDROCHLORIDE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, MEPOLIZUMAB, OXYCODONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RANITIDINE HYDROCHLORIDE, INFLIXIMAB, SULFASALAZINE, TOFACITINIB, TOFACITINIB CITRATE, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, VITAMIN C, VITAMIN C, ERGOCALCIFEROL, TOFACITINIB, TOFACITINIB, |
||||
| 1099 | 26765268 |
CA |
57 | 2 |
Drug hypersensitivity, Bladder disorder, Pain, Inappropriate schedule of product administration, Weight increased, Respiratory tract congestion, Asthma, Illness, Nasal congestion, Pain in extremity, Urinary tract infection, Peripheral swelling, Tenosynovitis, Sinusitis, Cough, Weight decreased, Arthritis, Nasal mucosal discolouration, |
||||
METHOTREXATE, METHOTREXATE SODIUM, GLYCOPYRROLATE, QUETIAPINE FUMARATE, QUETIAPINE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CICLESONIDE, CICLESONIDE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALBUTEROL SULFATE, |
||||
| 1100 | 26762739 |
US |
50 | 1 |
Asthma, Inappropriate schedule of product administration, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
